Obsidian Therapeutics
E1188106
UNEXPLORED
Obsidian Therapeutics is a biotechnology company focused on developing precision-controlled cell and gene therapies using engineered gene expression technologies.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Obsidian Therapeutics canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T15982905 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Obsidian Therapeutics Context triple: [Vertex Pharmaceuticals, collaboratesWith, Obsidian Therapeutics]
-
A.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence and machine learning to design optimized adeno-associated virus (AAV) gene therapy vectors.
-
B.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
C.
Innogen
Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
-
D.
Ridgeback Biotherapeutics
Ridgeback Biotherapeutics is a biotechnology company focused on developing antiviral and immunotherapy treatments for serious infectious diseases, including Ebola and COVID-19.
-
E.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Obsidian Therapeutics Target entity description: Obsidian Therapeutics is a biotechnology company focused on developing precision-controlled cell and gene therapies using engineered gene expression technologies.
-
A.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence and machine learning to design optimized adeno-associated virus (AAV) gene therapy vectors.
-
B.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
C.
Innogen
Innogen is the original name of Imogen, the virtuous and wronged heroine of William Shakespeare’s play "Cymbeline."
-
D.
Ridgeback Biotherapeutics
Ridgeback Biotherapeutics is a biotechnology company focused on developing antiviral and immunotherapy treatments for serious infectious diseases, including Ebola and COVID-19.
-
E.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.